Back to search
FDAFDA · Food and drugs·Recall number D-920-2013

Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50

Published September 4, 2013 · Recall initiated: May 25, 2013

Summary

FDA records drug Class I recall D-920-2013, published September 4, 2013 and initiated May 25, 2013. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 15,625 vials; Lot: Lot #: 6103882, Exp 10/14. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide
Lot
Lot #: 6103882, Exp 10/14
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50 recalled?

Yes. FDA published recall D-920-2013 on September 4, 2013. Reported hazard: Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.

What should I do if I have this product?

Voluntary: Firm initiated · Letter